Ann: BXN Signs Collaboration Agreement with Cy Biopharma AG, page-4

  1. 1,483 Posts.
    lightbulb Created with Sketch. 94
    Key numbers here is we are on track for $10m revenue for the year and a current MC of $10m.

    The April upgraded license was discussed in a stock head article where the CEO spoke of $8m in orders already over the last 2 months. "we have been inundated with client and manufacturing orders "
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.9¢
Change
0.002(4.26%)
Mkt cap ! $106.0M
Open High Low Value Volume
4.7¢ 4.9¢ 4.6¢ $79.21K 1.681M

Buyers (Bids)

No. Vol. Price($)
1 112638 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 657387 4
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.